Analyst	Recommendation	Action	Price target	Projected	Date
Matthew Cost Morgan Stanley	Hold	Maintained	$28.85	+919.4%	05/18/2026
Youssef Squali Truist Financial	Hold	Maintained	$28.85	+919.4%	11/06/2025

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	220.22M	199.17M	221.80M	173.90M
Cost of goods sold	97.41M	94.79M	93.79M	83.71M
Cost of revenue	97.41M	94.79M	93.79M	83.71M
Research and development expenses	26.04M	19.40M	17.57M	14.23M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	91.89M	87.93M	83.26M	70.59M
Operating expense	117.93M	107.34M	100.83M	84.82M
Total operating expenses	215.33M	202.12M	194.62M	168.53M
Operating income	4.89M	-2.95M	27.18M	5.37M
Other non operating income	-	-	-	-
EBT including unusual items	-19.62M	-49.38M	-160.93M	-200.52M
EBT excluding unusual items	851.00K	-6.07M	24.45M	3.54M
Income tax expense	-3.60M	-1.81M	-4.99M	-2.77M
Effective tax rate	18.36%	3.66%	3.10%	1.38%
Other operating expenses	-	-	-	-
Net income	-16.02M	-47.57M	-155.94M	-197.75M
Net profit margin	-7.27%	-23.88%	-70.31%	-113.72%
Earnings per share	0.67	0.58	-	-
Interest and investment income	771.00K	801.00K	479.00K	123.00K
Interest expense	-4.08M	-3.76M	-3.83M	-3.57M
Net interest expenses	-3.31M	-2.96M	-3.35M	-3.44M
Depreciation and amortization charges	-	-	-	-
EBITDA	17.22M	9.35M	39.20M	17.06M
Gain or loss from assets sale	-	-	-	-

Ask anything